Theo Ross: 2024 Women in Biopharma R&D
Theo Ross, M.D., Ph.D. CPI's, President and Chief Scientific Officer, was recognized as one of 20 women making an impact in Biopharma Research & Development in 2024 by Endpoints News. Dr. Ross serves as Vice President of Early Oncology R&D...
Conference BRCA 30 Years: Discovery to Impact
Women’s College Hospital (WCH), Toronto, Canada
Nov 4-5, 2024 - Hybrid Event
Women’s College Hospital (WCH), Toronto, Canada Nov 4-5, 2024 - Hybrid Event The Women’s College Hospital (WCH) has organized a special hybrid conference to celebrate the 30-year anniversary of the discovery of BRCA genes....
Damon Runyon Fellowship Award
CPI has partnered with Damon Runyon Research Foundation to promote research relevant to the development of molecular approaches (such as drugs and vaccines) for the prevention of inherited cancers. If an applicable proposal is selected by Damon...
A high-throughput approach to identify BRCA1-downregulating compounds to enhance PARP inhibitor sensitivity
A CPI grant funded Dr. Kotsopoulos at the University of Toronto, Toronto, Canada for Evaluating BRCA1 haploinsufficiency as a putative target for the prevention of BRCA1-associated cancer. She and her collaborators developed a cell-based test to...
2023 CPI Research Meeting
The second Cancer Prevention Initiative (CPI) Research Meeting was held on January 18th, 2023. Following the success of the first meeting in 2021, this event was again held virtually and was moderated by Dr. Larry Brody, Director of the Division of...
Inaugural CPI Research Meeting
The inaugural Cancer Prevention Initiative (CPI) Research Meeting was held on November 10, 2021. This virtual meeting featured CPI-funded researchers from around the globe. The meeting presented a lineup of top scientists and interesting topics...
CPI Announces Partnership with Southwestern Medical Foundation
Posted June 8, 2020 CPI is delighted to announce a new partnership with Southwestern Medical Foundation - a Dallas-based 501(c)(3) organization connecting the vision of donors with highly innovative programs on the leading edge of medical...
